The increasing demand in peptides has led a significant grey industry, presenting substantial risks to consumers. These materials are typically manufactured beyond rigorous regulatory oversight, meaning such quality and efficacy can be extremely inconsistent. In addition, these vendors may omit accurate details regarding components, likely unwanted